Drug major Lupin on Thursday said it will enter the digital healthcare space in India with a focus to provide a digital therapeutics platform for doctors and patients.
In a regulatory filing the company said “the board of directors has approved the company’s entry into the digital healthcare space...” The company said it has recently incorporated a new entity in the name of Lupin Digital Health Ltd, as a wholly-owned subsidiary, which will undertake this activity, the filing added.
Also read: Pharma majors bulk up Covid portfolio
Lupin, however, did not share any other details about the new venture.
Shares of Lupin Ltd were trading 0.29 per cent lower at ₹1,243.30 apiece on the BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.